Jonathan A. Fidler - Concepedia

Author

Jonathan A. Fidler

SynZyme Technologies (United States)

Also Known As

J.A. Fidler, Jonathan A Fidler, Jonathan A. Fidler, Jonathan Fidler

Publications

834

Citations

H-Index

Concepts

All Affiliations

SynZyme Technologies (United States)Emory University Atlanta VA Medical Center Beth Israel Deaconess Medical Center The Ohio State University

About

Jonathan A. Fidler is an author at SynZyme Technologies (United States) specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	370
2	Social Sciences	5	5	241
3	Anesthesia	2	2	51
4	Cell Biology	2	2	103
5	Behavioral Sciences	1	1	23

Jonathan A. Fidler

Publications

823

Citations

H-Index

Page 1

	Year	Citations
Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis James C. Dodge, Christopher M. Treleaven, Jonathan A. Fidler, Proceedings of the National Academy of Sciences	2013	127
AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice James C. Dodge, Christopher M. Treleaven, Jonathan A. Fidler, Molecular Therapy	2010	124
Temporal Neuropathologic and Behavioral Phenotype of 6<i><sup>neo</sup></i>/6<i><sup>neo</sup></i>Pompe Disease Mice Richard L. Sidman, Tatyana V. Taksir, Jonathan A. Fidler, Journal of Neuropathology & Experimental Neurology	2008	85
Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease James C. Dodge, Jennifer Clarke, Christopher M. Treleaven, Experimental Neurology Niemann–pick A DiseaseNeurodegenerative DiseasesIntracerebroventricular InfusionMolecular NeuroscienceNeurobiology Of Disease	2008	74
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse Marco A. Passini, Jie Bu, Jonathan A. Fidler, Proceedings of the National Academy of Sciences ImmunologySystemic InjectionsSocial SciencesNiemann-pick MouseNeuroinflammation	2007	67
Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe Mice Robin J. Ziegler, Scott D. Bercury, Jonathan A. Fidler, Human Gene Therapy Symptomatic Pompe MicePompe DiseaseMuscle FunctionSkeletal MusclePathogenesis	2008	61
Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia Seyed A. Safavynia, Glenda L. Keating, Iris Speigel, Anesthesiology	2016	52
Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse Wendy W. Yang, Richard L. Sidman, Tatyana V. Taksir, Experimental Neurology Neurodegenerative DiseasesAmyotrophic Lateral SclerosisDisease ProgressionNeurological DisorderExperimental Neuropathology	2010	45
The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in mice Jennifer Rha, Stephanie K. Jones, Jonathan A. Fidler, Human Molecular Genetics NeurogenomicsGeneticsTissue Specific DiseaseSynaptic SignalingSocial Sciences	2017	42
Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone Jonathan A. Fidler, Christopher M. Treleaven, Thomas J. Tamsett, The FASEB Journal	2011	35

Page 1